QQ客服 官方微博 反馈留言

	iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response
	Lu, Xue-Li[1]; Zhao, Cui-Hua[2]; Zhang, Han[3]; Yao, Xin-Liang[4]
刊名	BIOMEDICINE & PHARMACOTHERAPY
	2017
卷号	86页码:645-653
关键词	Cardiac injury Lipopolysaccharide iRhom2 Inflammation TLR-4/NF-kappa B
ISSN号	0753-3322
DOI	http://dx.doi.org/10.1016/j.biopha.2016.11.075
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5188544
专题	河南大学
作者单位	1.[1]Henan Univ, Huaihe Hosp, Dept Cardiol, Kaifeng 475000, Peoples R China. 2.[2]Henan Univ, Huaihe Hosp, Dept Cardiol, Kaifeng 475000, Peoples R China. 3.[3]Henan Univ, Huaihe Hosp, Dept Cardiol, Kaifeng 475000, Peoples R China. 4.[4]Henan Univ, Huaihe Hosp, Dept Cardiol, Kaifeng 475000, Peoples R China.
推荐引用方式 GB/T 7714	Lu, Xue-Li[1],Zhao, Cui-Hua[2],Zhang, Han[3],et al. iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response[J]. BIOMEDICINE & PHARMACOTHERAPY,2017,86:645-653.
APA	Lu, Xue-Li[1],Zhao, Cui-Hua[2],Zhang, Han[3],&Yao, Xin-Liang[4].(2017).iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response.BIOMEDICINE & PHARMACOTHERAPY,86,645-653.
MLA	Lu, Xue-Li[1],et al."iRhom2 is involved in lipopolysaccharide-induced cardiac injury in vivo and in vitro through regulating inflammation response".BIOMEDICINE & PHARMACOTHERAPY 86(2017):645-653.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。